Literature DB >> 34045422

Cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia.

R Bansal1, A Mahajan1, S Vichare1, Y Lokhandwala1.   

Abstract

Catecholaminergic polymorphic ventricular tachycardia (CPVT), a rare inheritable fatal arrhythmogenic disorder, is difficult to diagnose and is a challenge to manage. A 21-years-old man presented with recurrent exertional syncope and complex multifocal ventricular ectopy. CPVT was diagnosed based on the clinical criteria, despite the absence of some classical findings. The patient underwent cardiac sympathetic denervation (CSD) after lifestyle modification and pharmacological management were ineffective. CSD proved to be effective. The patient did not have any exertional symptoms or recurrence of syncope at follow-up period of 1 year. The present case report adds to the growing evidence in favour of CSD for CPVT.

Entities:  

Keywords:  Cardiac sympathectomy; sudden death; syncope

Mesh:

Year:  2022        PMID: 34045422      PMCID: PMC8860116          DOI: 10.4103/jpgm.JPGM_908_20

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN: 0022-3859            Impact factor:   1.476


  9 in total

Review 1.  How to perform and interpret provocative testing for the diagnosis of Brugada syndrome, long-QT syndrome, and catecholaminergic polymorphic ventricular tachycardia.

Authors:  Manoj N Obeyesekere; George J Klein; Simon Modi; Peter Leong-Sit; Lorne J Gula; Raymond Yee; Allan C Skanes; Andrew D Krahn
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-12

Review 2.  HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.

Authors:  Silvia G Priori; Arthur A Wilde; Minoru Horie; Yongkeun Cho; Elijah R Behr; Charles Berul; Nico Blom; Josep Brugada; Chern-En Chiang; Heikki Huikuri; Prince Kannankeril; Andrew Krahn; Antoine Leenhardt; Arthur Moss; Peter J Schwartz; Wataru Shimizu; Gordon Tomaselli; Cynthia Tracy
Journal:  Heart Rhythm       Date:  2013-08-30       Impact factor: 6.343

3.  Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest.

Authors:  Christian van der Werf; Krystien V Lieve; J Martijn Bos; Conor M Lane; Isabelle Denjoy; Ferran Roses-Noguer; Takeshi Aiba; Yuko Wada; Jodie Ingles; Ida S Leren; Boris Rudic; Peter J Schwartz; Alice Maltret; Frederic Sacher; Jonathan R Skinner; Andrew D Krahn; Thomas M Roston; Jacob Tfelt-Hansen; Heikki Swan; Tomas Robyns; Seiko Ohno; Jason D Roberts; Maarten P van den Berg; Janneke A Kammeraad; Vincent Probst; Prince J Kannankeril; Nico A Blom; Elijah R Behr; Martin Borggrefe; Kristina H Haugaa; Christopher Semsarian; Minoru Horie; Wataru Shimizu; Janice A Till; Antoine Leenhardt; Michael J Ackerman; Arthur A Wilde
Journal:  Eur Heart J       Date:  2019-09-14       Impact factor: 29.983

4.  Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias.

Authors:  Marmar Vaseghi; Parag Barwad; Federico J Malavassi Corrales; Harikrishna Tandri; Nilesh Mathuria; Rushil Shah; Julie M Sorg; Jean Gima; Kaushik Mandal; Luis C Sàenz Morales; Yash Lokhandwala; Kalyanam Shivkumar
Journal:  J Am Coll Cardiol       Date:  2017-06-27       Impact factor: 24.094

5.  Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation.

Authors:  Gaetano M De Ferrari; Veronica Dusi; Carla Spazzolini; J Martijn Bos; Dominic J Abrams; Charles I Berul; Lia Crotti; Andrew M Davis; Michael Eldar; Maria Kharlap; Asaad Khoury; Andrew D Krahn; Antoine Leenhardt; Christopher R Moir; Attilio Odero; Louise Olde Nordkamp; Thomas Paul; Ferran Rosés I Noguer; Maria Shkolnikova; Jan Till; Arthur A M Wilde; Michael J Ackerman; Peter J Schwartz
Journal:  Circulation       Date:  2015-05-27       Impact factor: 29.690

6.  Physical and Psychological Consequences of Left Cardiac Sympathetic Denervation in Long-QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia.

Authors:  Kathryn E Waddell-Smith; Kjetil N Ertresvaag; Jian Li; Krish Chaudhuri; Jackie R Crawford; James K Hamill; David Haydock; Jonathan R Skinner
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-07-29

7.  Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia.

Authors:  Meiso Hayashi; Isabelle Denjoy; Fabrice Extramiana; Alice Maltret; Nathalie Roux Buisson; Jean-Marc Lupoglazoff; Didier Klug; Miyuki Hayashi; Seiji Takatsuki; Elisabeth Villain; Joël Kamblock; Anne Messali; Pascale Guicheney; Joël Lunardi; Antoine Leenhardt
Journal:  Circulation       Date:  2009-04-27       Impact factor: 29.690

8.  Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia.

Authors:  Arthur A M Wilde; Zahurul A Bhuiyan; Lia Crotti; Mario Facchini; Gaetano M De Ferrari; Thomas Paul; Chiara Ferrandi; Dave R Koolbergen; Attilio Odero; Peter J Schwartz
Journal:  N Engl J Med       Date:  2008-05-08       Impact factor: 91.245

9.  Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.

Authors:  Christina Y Miyake; Gregory Webster; Richard J Czosek; Michal J Kantoch; Anne M Dubin; Kishor Avasarala; Joseph Atallah
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-05-11
  9 in total
  1 in total

1.  Cardiac sympathetic denervation: A wonder solution to channelopathy-related ventricular tachycardia and much more.

Authors:  P Barwad
Journal:  J Postgrad Med       Date:  2022 Jan-Mar       Impact factor: 1.476

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.